After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

R-Evolution Worldwide visits accredited genomics and clinical trial facilities at Ifakara Health Institute

Tanzania, Morogoro Region – Ifakara On the occasion of the NeuroSolve 2026 Annual Meeting, we had the privilege of visiting the local facilities where critical research and diagnostic work are

Read More

HIV-associated multimorbidity: a trial of a “screen and link” strategy post hospital admission to improve outcomes in adults in sub-Saharan Africa

Our organisation has submitted a project proposal titled MULTILINK-HIV under the European funding call HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage: Global collaboration action towards better prevention, treatment and clinical management of HIV coinfections or co-morbidities

Read More

Soap bubbles against coronavirus in Uganda too !

The “Soap bubbles against coronavirus” initiative is sparking interest in other African nations as well. Indeed a group of young Ugandan decided to come together and create a group of

Read More